Wang, J.; Zhou, Y.; Tang, X.; Yu, X.; Wang, Y.; Chan, S.; Song, X.; Tu, Z.; Zhang, Z.; Lu, X.;
et al. JND4135, a New Type II TRK Inhibitor, Overcomes TRK xDFG and Other Mutation Resistance In Vitro and In Vivo. Molecules 2022, 27, 6500.
https://doi.org/10.3390/molecules27196500
AMA Style
Wang J, Zhou Y, Tang X, Yu X, Wang Y, Chan S, Song X, Tu Z, Zhang Z, Lu X,
et al. JND4135, a New Type II TRK Inhibitor, Overcomes TRK xDFG and Other Mutation Resistance In Vitro and In Vivo. Molecules. 2022; 27(19):6500.
https://doi.org/10.3390/molecules27196500
Chicago/Turabian Style
Wang, Jie, Yang Zhou, Xia Tang, Xiuwen Yu, Yongjin Wang, Shingpan Chan, Xiaojuan Song, Zhengchao Tu, Zhimin Zhang, Xiaoyun Lu,
and et al. 2022. "JND4135, a New Type II TRK Inhibitor, Overcomes TRK xDFG and Other Mutation Resistance In Vitro and In Vivo" Molecules 27, no. 19: 6500.
https://doi.org/10.3390/molecules27196500
APA Style
Wang, J., Zhou, Y., Tang, X., Yu, X., Wang, Y., Chan, S., Song, X., Tu, Z., Zhang, Z., Lu, X., Zhang, Z., & Ding, K.
(2022). JND4135, a New Type II TRK Inhibitor, Overcomes TRK xDFG and Other Mutation Resistance In Vitro and In Vivo. Molecules, 27(19), 6500.
https://doi.org/10.3390/molecules27196500